Zobrazeno 1 - 10
of 126
pro vyhledávání: '"Tiziana Sampietro"'
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 41, Iss 9, Pp 805-807 (2022)
Externí odkaz:
https://doaj.org/article/96f4fffc88d64da394128364492911ae
Autor:
Chiara Caselli, Raffaele De Caterina, Jeff M Smit, Jonica Campolo, Mohammed El Mahdiui, Rosetta Ragusa, Alberto Clemente, Tiziana Sampietro, Aldo Clerico, Riccardo Liga, Gualtiero Pelosi, Silvia Rocchiccioli, Oberdan Parodi, Arthur Scholte, Jhuani Knuuti, Danilo Neglia, EVINCI and SMARTool
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract We assessed whether high triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) levels, expressed by an increased TG/HDL-C ratio, predict coronary atherosclerotic disease (CAD) outcomes in patients with stable angina. We stu
Externí odkaz:
https://doaj.org/article/400fcea6ae5041d587ad339d48050228
Autor:
Laura D’Erasmo, Antonio Gallo, Angelo Baldassare Cefalù, Alessia Di Costanzo, Samir Saheb, Antonina Giammanco, Maurizio Averna, Alessio Buonaiuto, Gabriella Iannuzzo, Giuliana Fortunato, Arturo Puja, Tiziana Montalcini, Chiara Pavanello, Laura Calabresi, Giovanni Battista Vigna, Marco Bucci, Katia Bonomo, Fabio Nota, Tiziana Sampietro, Francesco Sbrana, Patrizia Suppressa, Carlo Sabbà, Fabio Fimiani, Arturo Cesaro, Paolo Calabrò, Silvia Palmisano, Sergio D’Addato, Livia Pisciotta, Stefano Bertolini, Randa Bittar, Olga Kalmykova, Sophie Béliard, Alain Carrié, Marcello Arca, Eric Bruckert
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-12 (2021)
Abstract Background Homozygous familial hypercholesterolemia (HoFH) is a rare life-threatening condition that represents a therapeutic challenge. The vast majority of HoFH patients fail to achieve LDL-C targets when treated with the standard protocol
Externí odkaz:
https://doaj.org/article/d3d61cde509e4a539ecfd7328d4ab9a4
Autor:
Francesco Sbrana, Beatrice Dal Pino, Giovanni Donato Aquaro, Federico Bigazzi, Giuseppe Vergaro, Tiziana Sampietro
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 41, Iss 5, Pp 437-439 (2022)
Externí odkaz:
https://doaj.org/article/c269d3b6e2ab433cbebd99a78f210c7f
Autor:
Laura D’Erasmo, Antonina Giammanco, Patrizia Suppressa, Chiara Pavanello, Gabriella Iannuzzo, Alessia Di Costanzo, Daniele Tramontano, Ilenia Minicocci, Simone Bini, Anja Vogt, Kim Stewards, Jeanine Roeters Van Lennep, Stefano Bertolini, Marcello Arca, the Italian and European Working Group on Lomitapide in HoFH, Maurizio Averna, Eric Boersma, Katia Bonomo, Marco Bucci, Laura Calabresi, Paolo Calabrò, Angelo Baldassare Cefalù, Jaimini Cegla, Arturo Cesaro, Sergio D’Addato, Eugene Daphnis, Maria Donata Di Taranto, Avishay Ellis, Fabio Fimiani, Giuliana Fortunato, Marco Gentile, Meral Kayikcioglu, Genovefa Kolovou, Evangelos Liberopoulos, Karin Littmann, Sergio Martínez-Hervás, Tiziana Montalcini, Fabio Nota, Livia Pisciotta, Arturo Puja, Giovanni José Real, Jeanine Roeters van Lennep, Joost Rutten, Carlo Sabbà, Tiziana Sampietro, Francesco Sbrana, Kim Steward, Fulvio Ventura, Battista Vigna, Shahenaz Walji
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Backgroundand aim: Autosomal recessive hypercholesterolemia (ARH) is a rare autosomal recessive disorder of low-density lipoprotein (LDL) metabolism caused by pathogenic variants in the LDLRAP1 gene. Like homozygous familial hypercholesterolemia, ARH
Externí odkaz:
https://doaj.org/article/c310a706a0ae42eda26ba363b9582898
Progression of chronic kidney disease in familial LCAT deficiency: a follow-up of the Italian cohort
Autor:
Chiara Pavanello, Alice Ossoli, Marcello Arca, Laura D'Erasmo, Giuliano Boscutti, Loreto Gesualdo, Tiziano Lucchi, Tiziana Sampietro, Fabrizio Veglia, Laura Calabresi
Publikováno v:
Journal of Lipid Research, Vol 61, Iss 12, Pp 1784-1788 (2020)
Familial LCAT deficiency (FLD) is a rare genetic disorder of HDL metabolism, caused by loss-of-function mutations in the LCAT gene and characterized by a variety of symptoms including corneal opacities and kidney failure. Renal disease represents the
Externí odkaz:
https://doaj.org/article/d17ab7275e0249ff82831ad20ff06ec2
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 40, Iss 3, Pp 225-227 (2021)
Externí odkaz:
https://doaj.org/article/f3112fcdee99458a879afc9f32696926
Autor:
Monica Gomaraschi, Alice Ossoli, Samuela Castelnuovo, Sara Simonelli, Chiara Pavanello, Gloria Balzarotti, Marcello Arca, Alessia Di Costanzo, Tiziana Sampietro, Gaetano Vaudo, Damiano Baldassarre, Fabrizio Veglia, Guido Franceschini, Laura Calabresi
Publikováno v:
Journal of Lipid Research, Vol 58, Iss 5, Pp 994-1001 (2017)
The aim of this study was to evaluate the vasoprotective effects of HDL isolated from carriers of LCAT deficiency, which are characterized by a selective depletion of LpA-I:A-II particles and predominance of preβ migrating HDL. HDLs were isolated fr
Externí odkaz:
https://doaj.org/article/7a34f0f2a30043a1ae83e0c728243ac8
Publikováno v:
Therapeutic Apheresis and Dialysis.
Autor:
d'Erasmo, Laura, Steward, Kim, Cefalù, Angelo Baldassare, Di Costanzo, Alessia, Boersma, Eric, Bini, Simone, Arca, Marcello, van Lennep, Jeanine Roeters, Antonina Giammanco, Maurizio Averna, Gabriella Iannuzzo, Giuliana Fortunato, Marco Gentile, Arturo Puja, Tiziana Montalcini, Chiara Pavanello, Laura Calabresi, Giovanni Battista Vigna, Marco Bucci, Katia Bonomo, Fabio Nota, Tiziana Sampietro, Francesco Sbrana, Patrizia Suppressa, Carlo Sabbà, Fabio Fimiani, Arturo Cesaro, Paolo Calabrò, Fulvio Ventura, Sergio D’Addato, Livia Pisciotta, Stefano Bertolini, Genovefa Kolovou, Evangelos Liberopoulos, Eugene Daphnis, Joost Rutten, Anja Vogt, Jaimini Cegla, Shahenaz Walji, Meral Kayikcioglu, José Real, Sergio Martínez-Hervás, Avishay Ellis, Karin Littmann
Publikováno v:
European Journal of Preventive Cardiology. SAGE Publications Ltd
European Journal of Preventive Cardiology, 29(5), 832-841. SAGE Publications Ltd
European Journal of Preventive Cardiology, 29(5), 832-841. SAGE Publications Ltd
Aims Lomitapide is a lipid-lowering agent indicated as an adjunct therapy for adult homozygous familial hypercholesterolaemia (HoFH). This study evaluated the medium-term effectiveness and safety of lomitapide in a large cohort of HoFH patients in Eu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4e5a3529b5b1b0118d231da6d97b6e
http://hdl.handle.net/11588/885541
http://hdl.handle.net/11588/885541